23-Jun-2022 | Zion Market Research
The global kidney stone management market was worth around USD 1.74 billion in 2021 and it is expected to surpass the value of USD 2.31 billion from 2022 to 2028 at a 7.12% CAGR during the forecast period. Hard deposits consisting of minerals and salts that form in the kidneys are known as renal calculi, urolithiasis, or kidney stones. The body's minerals crystallize when the urine becomes concentrated, which leads to the formation of stones. The usage of specific supplements and drugs, as well as certain medical disorders including excess body weight, are the main sources of such deposits. The urinary tract needs surgical help when the deposits get clogged. There are several methods for treating the stones, including extracorporeal shock wave lithotripsy, uteroscopy, and percutaneous nephrolithotomy.
The global kidney stone management market is primarily fueled due to an increase in kidney stone incidence and recurrence rates. Additionally, the market would benefit from the enhancement in the easiness of stone detection and the rise in technological development. Also, the market expansion is anticipated to profit from several initiatives implemented by the government and private sector players to raise awareness about the prevention of chronic renal diseases. The benefits of early kidney stone detection and prompt treatment will also increase the need for the management of nephrolithiasis in healthcare organizations. Furthermore, the market is anticipated to gain the most share in the near future due to research & development on minimally invasive surgical techniques, new product launches, and an increase in unhealthful eating habits that include packaged foods. However, during the forecast period, the expansion of the kidney stone management sector may be constrained by a lack of knowledge about surgical procedures and the availability of alternative treatment options.
The kidney stone management market was negatively impacted by the COVID-19 outbreak, which caused a decline in revenue. Kidney stone disease diagnostic rates were slow as a result of the lockdown brought on by the pandemic. The lockdown forced numerous small hospitals and nursing homes to temporarily cease operations. This was done in an effort to stop the spread of diseases and the diversion of medical resources for the treatment of COVID-19 patients. The kidney stone management market is being held back by a slow rate of medical device production, a lack of raw materials, and issues with supply chain management. However, with ease in regulations on movement and smooth operations of the healthcare industries, the market is expected to grow significantly during the forecast period.
The global kidney stone management market is divided based on type, end-user, and region. The market is divided into three main segments based on the type: lithotripsy, ureteroscopy, & percutaneous Nephrolithotomy. Based on end-user, the segments are as follows: hospitals, specialty clinics & surgical centers.
Geographically, North America now dominates the market for the management of kidney stones worldwide. The U.S., which has the highest reoccurrence and incidence of kidney stones, is the region's main source of power. High per capita healthcare spending, modern medical centers that provide the best & most up-to-date care, and awareness of the range of minimally invasive therapies available are all boosting the market in this region. Europe is a crucial market as well. The kidney stone management market in Europe receives the biggest support from the UK and Germany as many people prefer undergoing screening for renal illnesses as a result of increased knowledge regarding overall kidney health. The kidney stone management market in Asia Pacific is reportedly driven mostly by the developing nations of China and India. The region's market is mostly boosted by the growing older population.
The major players in the global kidney stone management market which are currently dominating the industry are MorphoSys AG, Dyax Corp., Creative-Biolabs, Abzena Plc., and AnaptysBio, Inc. Some of the other companies are Karl Storz GmbH & Co. Ltd., DirexGroup, Dornier MedTech, EDAP TMS, Lumenis Ltd., Elmed Medical System, Siemens Healthineers, Olympus Corporation, Cook Medical, and Boston Scientific Corporation
Browse the full “Kidney Stone Management Market By Type (Lithotripsy, Ureteroscopy, And Percutaneous Nephrolithotomy), By End-User (Hospitals, Specialty Clinics, And Surgical Centers), And By Region: – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/kidney-stones-management-market
The global kidney stone management market is segmented as follows:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651